Optimal diuretic strategies in heart failure

被引:8
|
作者
Suri, Sarabjeet S. [1 ]
Pamboukian, Salpy V. [1 ]
机构
[1] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA
关键词
Heart failure (HF); diuresis; diuretic resistance; FUROSEMIDE; TOLVAPTAN;
D O I
10.21037/atm-20-4600
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Heart failure (HF) is one of the major causes of morbidity and mortality in the world. According to a 2019 American Heart Association report, about 6.2 million American adults had HF between 2013 and 2016, being responsible for almost 1 million admissions. As the population ages, the prevalence of HF is anticipated to increase, with 8 million Americans projected to have HF by 2030, posing a significant public health and financial burden. Acute decompensated HF (ADHF) is a syndrome characterized by volume overload and inadequate cardiac output associated with symptoms including some combination of exertional shortness of breath, orthopnea, paroxysmal nocturnal dyspnea (PND), fatigue, tissue congestion (e.g., peripheral edema) and decreased mentation. The pathology is characterized by hemodynamic abnormalities that result in autonomic imbalance with an increase in sympathetic activity, withdrawal of vagal activity and neurohormonal activation (NA) resulting in increased plasma volume in the setting of decreased sodium excretion, increased water retention and in turn an elevation of filling pressures. These neurohormonal changes are adaptive mechanisms which in the short term are associated with increased contractility of the left ventricular (LV) and improvement in cardiac output. But chronically, the failing heart is unable to overcome the excessive pressure and volume leading to worsening HF. The primary symptomatic management of ADHF includes intravenous (IV) diuresis to help with decongestion and return to euvolemic status. Even though diuretics have not been shown to provide any mortality benefit, they have been clinically proven to be of significant benefit in the acute decompensated phase, as well as in chronic management of HF. Loop diuretics remain the mainstay of therapy for symptomatic management of HF with use of thiazide diuretics for synergistic effect in the setting of diuretic resistance. Poor diuretic efficacy has been linked with higher mortality and increased rehospitalizations.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Diuretic Resistance in Heart Failure
    Gupta R.
    Testani J.
    Collins S.
    Current Heart Failure Reports, 2019, 16 (2) : 57 - 66
  • [22] Diuretic resistance in heart failure
    Trullas, Joan Carles
    Casado, Jesus
    MEDICINA CLINICA, 2024, 162 (01): : 19 - 21
  • [23] Diuretic Treatment in Heart Failure
    Berczeller, Peter H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (07): : 683 - 683
  • [24] Heart failure and diuretic treatment
    Ege, M. R.
    Yilmaz, M. B.
    MINERVA CARDIOANGIOLOGICA, 2013, 61 (06): : 701 - 701
  • [25] Diuretic Resistance in Heart Failure
    Rahman, Rubayat
    Paz, Pablo
    Elmassry, Mohamed
    Mantilla, Barbara
    Dobbe, Logan
    Shurmur, Scott
    Nugent, Kenneth
    CARDIOLOGY IN REVIEW, 2021, 29 (02) : 73 - 81
  • [26] REPLY: Diuretic Strategies and Renal Dysfunction in Heart Failure With Preserved Ejection Fraction
    Sharma, Kavita
    Vaishnav, Joban
    Russell, Stuart D.
    JACC-HEART FAILURE, 2018, 6 (12) : 1050 - 1050
  • [27] Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure
    Yayla, Cagri
    Akyel, Ahmet
    Canpolat, Ugur
    Yayla, Kadriye Gayretli
    Eyiol, Azmi
    Akboga, Mehmet Kadri
    Turkoglu, Sedat
    Tavil, Yusuf
    Boyaci, Bulent
    Cengel, Atiye
    HERZ, 2015, 40 (08) : 1115 - 1120
  • [28] Association Between Home Diuretic Dose and Optimal Initial Intravenous Diuretic Dosing in Acute Decompensated Heart Failure
    Jacobs, Joshua A.
    Carter, Spencer J.
    Bullock, Griffin
    Carey, Jessica R.
    Pan, Irene Z.
    Kinsey, Mary Shea
    Zheutlin, Alexander R.
    Kapelios, Chris J.
    Raju, Shilpa
    Fang, James C.
    Shah, Kevin S.
    Bress, Adam P.
    CIRCULATION, 2023, 148
  • [29] Time to Diuretic in Acute Heart Failure
    Wussler, Desiree
    Walter, Joan
    de Lavallaz, Jeanne du Fay
    Strebel, Ivo
    Mueller, Christian
    JACC-HEART FAILURE, 2018, 6 (08) : 722 - 722
  • [30] Comparison of diuretic strategies in diuretic-resistant acute heart failure: a systematic review and network meta-analysis
    Orso, D.
    Tavazzi, G.
    Corradi, F.
    Mearelli, F.
    Federici, N.
    Peric, D.
    D'Andrea, N.
    Santori, G.
    Mojoli, F.
    Forfori, F.
    Vetrugno, L.
    Bove, T.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (07) : 2971 - 2980